| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |